Yang S, Wang M, Wang T, Sun M, Huang H, Shi X
It is important to recognize that the cardiovascular and renal benefits of GLP-1 medications typically outweigh the potential for retinopathy progression in appropriately selected patients, and discontinuing these medications due to unfounded concerns about vision may result in worse overall health outcomes
Bottom line Semaglutide can go with you wherever you go, as long as you plan ahead
Additionally, a 2024 commentary in Nature Reviews Endocrinology suggested that the future of GLP-1 use may be individualized dosing , guided by biomarker response and patient goals
It appears to interact with key biological systems, such as the nitric oxide pathway and antioxidant defenses, which may explain its broad therapeutic effects
OK, But What Do GLP-1 Users Actually Do Differently